Fluorescent and photo-affinity enkephalin derivatives: preparation and interaction with opiate receptors. 1979

E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D000345 Affinity Labels Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. Affinity Labeling Reagents,Labeling Reagents, Affinity,Labels, Affinity,Reagents, Affinity Labeling
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
February 1978, Life sciences,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
December 1989, Biochemistry international,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
November 1978, Molecular pharmacology,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
August 1987, Biochemical and biophysical research communications,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
October 1985, Chemical & pharmaceutical bulletin,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
July 1978, Biochemical and biophysical research communications,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
April 1980, European journal of pharmacology,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
January 1996, Eksperimental'naia i klinicheskaia farmakologiia,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
July 1976, Biochemical and biophysical research communications,
E Hazum, and K J Chang, and Y Shechter, and S Wilkinson, and P Cuatrecasas
November 1985, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!